Skip to main content
. 2021 May 21;11:678253. doi: 10.3389/fonc.2021.678253

Figure 4.

Figure 4

Validation of the GID-lncRNAs based risk signature. (A) Survival analysis in training dataset. (B) Survival analysis in testing dataset. (C) ROC analysis for evaluating the predictive efficiency of the risk signature in the training dataset. (D) ROC analysis for evaluating the predictive efficiency of the risk signature in the testing dataset. (E) Results of Univariate Cox regression. (F) Results of Multivariate Cox regression.